Hall P F
Department of Endocrinology, Prince of Wales Hospital, Randwick, NSW, Australia.
J Steroid Biochem Mol Biol. 1995 Dec;55(5-6):601-5. doi: 10.1016/0960-0760(95)00211-1.
Much of the cholesterol used in steroid synthesis is stored in lipid droplets in the cytoplasm of steroid-forming cells. The cholesterol ester in these droplets is transported to the inner mitochondrial membrane where it enters the pathway to steroid hormones as free cholesterol--the substrate for the first enzyme, namely P450scc. It has been shown that this transport process governs the rate of steroid synthesis and is specifically stimulated by ACTH and its second messenger. The stimulating influence of ACTH on cholesterol transport is inhibited by cytochalasins, by monospecific anti-actin and by DNase I demonstrating that the steroidogenic cell must possess a pool of monomeric actin available for polymerization to F actin if it is to respond to ACTH and cyclic AMP. It has been shown that the two structures involved in cholesterol transport (droplets and mitochondria) are both bound to vimentin intermediate filaments in adrenal and Leydig cells. In addition these filaments are closely associated with the circumferential actomyosin ring in which they are crosslinked by actin microfilaments. In permeabilized adrenal cells Ca2+/calmodulin phosphorylates vimentin and this change is known to disrupt intermediate filaments and to cause contraction of actomyosin by phosphorylating myosin light chain kinase. Ca2+/calmodulin stimulated cholesterol transport and steroid synthesis and causes rounding of the responding cells by contraction of the actomyosin, if ATP is also added at the same time. Other agents that disrupt intermediate filaments include anti-vimentin plus ATP in permeabilized cells which also results in rounding of the cell. Acrylamide exerts a similar effect in intact adrenal cells and in addition causes rounding of the cells and increase in steroid synthesis without increase in cyclic AMP. It is also known that if adrenal cells are grown on surfaces treated with poly(HEMA), the cells grow in rounded form and steroid synthesis is increased in proportion to the degree of rounding (r = 0.92). This response does not involve increase in cellular levels of cyclic AMP. It is proposed that in vivo where the cell is always round and cannot show more than strictly limited change in shape, ACTH activates Ca2+/calmodulin possibly by redistributing cellular Ca2+. Ca2+/calmodulin in turn promotes phosphorylation of vimentin and myosin light chain. The first of these phosphorylations shortens intermediate filaments and the second promotes contraction of the actomyosin ring with internal shortening and approximation of lipid droplets and mitochondria. Details of the earlier events (activation of Ca2+/calmodulin) and later changes (transfer of cholesterol to the inner membrane) remain to be elucidated. It is clear however that the action of ACTH requires increase in cellular cyclic AMP. These experimental responses bypass this step in the response to ACTH.
类固醇合成过程中使用的大部分胆固醇都储存在类固醇生成细胞胞质中的脂滴中。这些脂滴中的胆固醇酯被转运到线粒体内膜,在那里它以游离胆固醇的形式进入类固醇激素合成途径——游离胆固醇是第一种酶即P450scc的底物。研究表明,这种转运过程决定了类固醇合成的速率,并受到促肾上腺皮质激素(ACTH)及其第二信使的特异性刺激。细胞松弛素、单特异性抗肌动蛋白和脱氧核糖核酸酶I可抑制ACTH对胆固醇转运的刺激作用,这表明类固醇生成细胞必须拥有一组可用于聚合成F-肌动蛋白的单体肌动蛋白,才能对ACTH和环磷酸腺苷作出反应。研究表明,参与胆固醇转运的两种结构(脂滴和线粒体)都与肾上腺细胞和睾丸间质细胞中的波形蛋白中间丝结合。此外,这些细丝与周向肌动球蛋白环紧密相连,在环中它们通过肌动蛋白微丝交联。在透化的肾上腺细胞中,Ca2+/钙调蛋白使波形蛋白磷酸化,已知这种变化会破坏中间丝,并通过使肌球蛋白轻链激酶磷酸化导致肌动球蛋白收缩。如果同时添加ATP,Ca2+/钙调蛋白会刺激胆固醇转运和类固醇合成,并通过肌动球蛋白的收缩使反应细胞变圆。其他破坏中间丝的试剂包括透化细胞中的抗波形蛋白加ATP,这也会导致细胞变圆。丙烯酰胺在完整的肾上腺细胞中也有类似作用,此外还会使细胞变圆并增加类固醇合成,而不会增加环磷酸腺苷。还已知,如果肾上腺细胞在经聚(甲基丙烯酸羟乙酯)处理的表面上生长,细胞会呈圆形生长,类固醇合成会随着变圆程度的增加而增加(r = 0.92)。这种反应不涉及细胞内环磷酸腺苷水平的增加。有人提出,在体内细胞总是圆形且形状变化严格受限的情况下,ACTH可能通过重新分布细胞内的Ca2+来激活Ca2+/钙调蛋白。Ca2+/钙调蛋白进而促进波形蛋白和肌球蛋白轻链的磷酸化。这些磷酸化中的第一个会缩短中间丝,第二个会促进肌动球蛋白环的收缩,导致内部缩短以及脂滴和线粒体靠近。早期事件(Ca2+/钙调蛋白的激活)和后期变化(胆固醇向内膜的转移)的细节仍有待阐明。然而很明显,ACTH的作用需要细胞内环磷酸腺苷增加。这些实验反应绕过了对ACTH反应中的这一步骤。